3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Uterine Cervical Neoplasms
2
Solid Tumors
2
Ovarian Neoplasms
2
Neoplasms
2
Lung Neoplasms
2
Advanced Malignant Solid Neoplasm
2
Vaginal Neoplasms
1
Triple-negative Metastatic Breast Cancer
1
Triple Negative Breast Neoplasms
1
Tongue Neoplasms
1
Stomach Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Rhabdomyosarcoma
1
Previously Treated Non Small Cell Lung Cancer
1
Platinum Refractory Extensive-Stage Small Cell Lung Carcinoma
1
Pinealoma
1
Ovarian, Fallopian Tube, Peritoneal Cancer, P53 Mutation
1
Neuroectodermal Tumors, Primitive
1
Neuroblastoma
1
Neoplasm Metastasis
1
Myelodysplastic-Myeloproliferative Diseases
1
Metastatic Pancreatic Adenocarcinoma
1
Meningeal Carcinomatosis
1
Medulloblastoma
1
Lymphoid Interstitial Pneumonia
1
Leukemia, Myelomonocytic, Chronic
1
Leukemia, Myeloid, Acute
1
Head and Neck Neoplasms
1
Gliosarcoma
1
Glioblastoma
1
Interventions
Cisplatin
9
Cetuximab
6
Radiotherapy, Intensity-Modulated
5
Docetaxel
4
Radiotherapy
3
Fluorouracil
3
Carboplatin
3
pembrolizumab
2
durvalumab
2
Radiation
2
Hydroxyurea
2
Drug Therapy
2
Celecoxib
2
Bupropion
2
130-nm albumin-bound paclitaxel
2
1,2-diaminocyclohexaneplatinum II citrate
2
sodium thiosulfate
1
gossypol acetic acid
1
Varenicline
1
Transcutaneous Electric Nerve Stimulation
1
Tobacco Use Cessation Devices
1
Psychiatric Rehabilitation
1
Polymerase Chain Reaction
1
Platinum
1
Pilocarpine
1
Oral Hygiene
1
Nicotine Replacement Therapy
1
Nicotine
1
NVP-BKM120
1
Immunoglobulin G
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Laryngeal Neoplasms
×
adavosertib
×
Clear all
No trials found.